Top

World Journal of Surgery

Published in:

01-11-2015 | Original Scientific Report

Staging Laparoscopy for Patients with cM0, Type 4, and Large Type 3 Gastric Cancer

Authors: Yuichiro Miki, Masanori Tokunaga, Yutaka Tanizawa, Etsuro Bando, Taiichi Kawamura, Masanori Terashima

Published in: World Journal of Surgery | Issue 11/2015

Abstract

Background

Staging laparoscopy (SL) is considered useful for detecting peritoneal metastasis, a task that is difficult using conventional imaging modalities. However, indications for the procedure remain unclear, with differences evident across reports. The present study aimed to clarify the effectiveness and limitations of SL for patients with type 4 and large type 3 gastric cancer.

Methods

We included 88 patients with cM0, type 4 or large type 3 gastric cancer who underwent SL at the Shizuoka Cancer Center from August 2008 to June 2014, to determine the detection rate of peritoneal metastasis by SL. In addition, we calculated the false-negative rate of SL by recruiting patients who were diagnosed as P0 at SL and underwent laparotomy within 28 days after the SL.

Results

P0CY0, P0CY1, P1CY0, and P1CY1 were diagnosed in 41 (46.6 %), 15 (17.0 %), 15 (17.0 %), and 17 (19.3 %) patients, respectively. Accordingly, clinically non-evident peritoneal metastasis was found in 36.3 % of patients, and 53.4 % of patients were diagnosed with stage IV. In addition, 29 patients diagnosed as P0 at SL underwent laparotomy within 28 days after the SL. Among them, peritoneal metastasis was found in five patients. Thus, the false-negative rate was 17.2 % (5/29, 95 % CI 7.6–34.6 %).

Conclusions

SL is useful for detecting previously unsuspected peritoneal metastasis and for avoiding unnecessary laparotomy, although the high false-negative rate cannot be ignored. Patients with cM0, type 4, and large type 3 gastric cancer are considered suitable candidates for SL.

Sasako M (2003) Principles of surgical treatment for curable gastric cancer. J Clin Oncol 21:274s–275sCrossRefPubMed

Koizumi W, Narahara H, Hara T et al (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215–221CrossRefPubMed

Asencio F, Aguilo J, Salvador JL et al (1997) Video-laparoscopic staging of gastric cancer. A prospective multicenter comparison with noninvasive techniques. Surg Endosc 11:1153–1158CrossRefPubMed

Burbidge S, Mahady K, Naik K (2013) The role of CT and staging laparoscopy in the staging of gastric cancer. Clin Radiol 68:251–255CrossRefPubMed

Burke EC, Karpeh MS, Conlon KC et al (1997) Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 225:262–267PubMedCentralCrossRefPubMed

D’Ugo DM, Persiani R, Caracciolo F et al (1997) Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy. Surg Endosc 11:1159–1162CrossRefPubMed

Muntean V, Mihailov A, Iancu C et al (2009) Staging laparoscopy in gastric cancer. Accuracy and impact on therapy. J Gastrointestin Liver Dis 18:189–195PubMed

Nakagawa S, Nashimoto A, Yabusaki H (2007) Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer 10:29–34CrossRefPubMed

Romijn MG, van Overhagen H, Spillenaar Bilgen EJ et al (1998) Laparoscopy and laparoscopic ultrasonography in staging of oesophageal and cardial carcinoma. Br J Surg 85:1010–1012CrossRefPubMed

10.

Sarela AI, Lefkowitz R, Brennan MF et al (2006) Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg 191:134–138CrossRefPubMed

11.

Shimizu H, Imamura H, Ohta K et al (2010) Usefulness of staging laparoscopy for advanced gastric cancer. Surg Today 40:119–124CrossRefPubMed

12.

Tourani SS, Cabalag C, Link E et al (2015) Laparoscopy and peritoneal cytology: important prognostic tools to guide treatment selection in gastric adenocarcinoma. ANZ J Surg 85:69–73CrossRefPubMed

13.

Yamagata Y, Amikura K, Kawashima Y et al (2013) Staging laparoscopy in advanced gastric cancer: usefulness and issues requiring improvement. Hepatogastroenterology 60:751–755PubMed

14.

Iwasaki Y, Sasako M, Yamamoto S et al (2013) Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol 107:741–745CrossRefPubMed

15.

TNM-Classification of Malignant Tumours (2009). Wiley-Blackwell, New York

16.

Japanese Gastric Cancer A A (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112CrossRef

17.

Sasako M, Maruyama K, Kinoshita T et al (1992) Neoadjuvant che-motherapy for gastric cancer: indication and trial setting (in Jap-anese). Shokakigeka 15:159–167

18.

Cabalag CS, Chan ST, Kaneko Y et al (2015) A systematic review and meta-analysis of gastric cancer treatment in patients with positive peritoneal cytology. Gastric Cancer 18:11–22CrossRefPubMed

19.

De Andrade JP, Mezhir JJ (2014) The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review. J Surg Oncol 110:291–297CrossRefPubMed

20.

Okabe H, Ueda S, Obama K et al (2009) Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol 16:3227–3236CrossRefPubMed

21.

Kodera Y, Ito S, Mochizuki Y et al (2009) A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol 35:1158–1163CrossRefPubMed

22.

Ishigami H, Kitayama J, Kaisaki S et al (2010) Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol 21:67–70CrossRefPubMed

23.

Ishigami H, Kitayama J, Otani K et al (2009) Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer. Oncology 76:311–314CrossRefPubMed

24.

Yano M, Tsujinaka T, Shiozaki H et al (2000) Appraisal of treatment strategy by staging laparoscopy for locally advanced gastric cancer. World J Surg 24:1130–1135. doi:10.1007/s002680010183; discussion 1135–1136 CrossRefPubMed

Title: Staging Laparoscopy for Patients with cM0, Type 4, and Large Type 3 Gastric Cancer
Authors: Yuichiro Miki
Masanori Tokunaga
Yutaka Tanizawa
Etsuro Bando
Taiichi Kawamura
Masanori Terashima
Publication date: 01-11-2015
Publisher: Springer International Publishing
Published in: World Journal of Surgery / Issue 11/2015
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-015-3144-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Staging Laparoscopy for Patients with cM0, Type 4, and Large Type 3 Gastric Cancer

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2015

Is There Justification for Total Thyroidectomy in Low-Risk Papillary Thyroid Carcinoma? A Decision-Analysis Model

Distal Enteral Feeding Helps Blood Sugar Control in Pancreatectomized Patients

The Clinical Impact of 6-Min Walk Test Distance as a Predictor of Complications in Patients Undergoing Major Surgery

Essential Surgery: The Way Forward: Reply

Safety and Hemostatic Effectiveness of the Fibrin Pad for Severe Soft-Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic (Non-cardiac) Surgery: A Randomized, Controlled, Superiority Trial

A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901)